UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial

Canadian Medical Association journal (CMAJ), 2012-07, Vol.184 (10), p.1143

2012

Volltextzugriff (PDF)

Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment

The New England journal of medicine, 2005-06, Vol.352 (23), p.2379-2388

2005

Volltextzugriff (PDF)

Impact of potential modifications to Alzheimer's disease clinical trials in response to disruption by COVID-19: a simulation study

Alzheimer's research & therapy, 2021-12, Vol.13 (1), p.201-201, Article 201

2021

Volltextzugriff (PDF)

Development of a novel cognitive composite outcome to assess therapeutic effects of exercise in the EXERT trial for adults with MCI: The ADAS‐Cog‐Exec

Alzheimer's & dementia : translational research & clinical interventions, 2020, Vol.6 (1), p.e12059-n/a

2020

Volltextzugriff (PDF)

Incidence of new-onset seizures in mild to moderate Alzheimer disease

Archives of neurology (Chicago), 2012-03, Vol.69 (3), p.368

2012

Volltextzugriff (PDF)

Depressed mood in informal caregivers of individuals with mild cognitive impairment

American journal of Alzheimer's disease and other dementias, 2007-08, Vol.22 (4), p.273

2007

Volltextzugriff (PDF)

High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2008-10, Vol.300 (15), p.1774

2008

Volltextzugriff (PDF)

A Phase 2a proof‐of‐concept double‐blind, randomized, placebo‐controlled trial of nicotinamide in early Alzheimer’s disease

Alzheimer's & dementia, 2023-12, Vol.19 (S21), p.n/a

2023

Volltextzugriff (PDF)

Spanish instrument protocol : New treatment efficacy instruments for spanish-speaking patients in Alzheimer disease clinical trials

Alzheimer disease and associated disorders, 2006-10, Vol.20 (4), p.232-241

2006

Volltextzugriff (PDF)

Memantine and Acetylcholinesterase Inhibitor Use in Alzheimer's Disease Clinical Trials: Potential for Confounding by Indication

Journal of Alzheimer's disease, 2019-01, Vol.67 (2), p.707

2019

Volltextzugriff (PDF)

Topline Results of EXERT: Can Exercise Slow Cognitive Decline in MCI?

Alzheimer's & dementia, 2022-12, Vol.18 (S11), p.n/a

2022

Volltextzugriff (PDF)

Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2003-06, Vol.289 (21), p.2819

2003

Volltextzugriff (PDF)

Birth outcomes in women who have taken leflunomide during pregnancy

Arthritis and rheumatism, 2010-05, Vol.62 (5), p.1494-1503

2010

Volltextzugriff (PDF)

Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia

Archives of neurology (Chicago), 2007-01, Vol.64 (1), p.108

2007

Volltextzugriff (PDF)

Sample size requirements for training to a kappa agreement criterion on clinical dementia ratings

Alzheimer disease and associated disorders, 2010-07, Vol.24 (3), p.264-268

2010

Volltextzugriff (PDF)

ADCS prevention instrument project: pharmacoeconomics : Assessing health-related resource use among healthy elderly

Alzheimer disease and associated disorders, 2006-10, Vol.20 (4), p.S191-S202

2006

Volltextzugriff (PDF)

The multicenter AIDS cohort study : retention after 91/2 years

American journal of epidemiology, 1995-08, Vol.142 (3), p.323-330

1995

Volltextzugriff (PDF)

The Multicenter AIDS Cohort Study: retention after 9 1/2 years

American journal of epidemiology, 1995-08, Vol.142 (3), p.323-330

1995

Volltextzugriff (PDF)

Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials

Archives of neurology (Chicago), 2004-01, Vol.61 (1), p.59

2004

Volltextzugriff (PDF)

S3-02-01: ADCS homocysteine trial

Alzheimer's & dementia, 2007-07, Vol.3 (3), p.S199-S199

2007

Volltextzugriff (PDF)

S3-02-01

Alzheimer's & dementia, 2007, Vol.3 (3), p.S199-S199

2007

Volltextzugriff (PDF)

P1-003 ADCS Prevention instrument project: assessment of activities of daily living (ADL)

Neurobiology of aging, 2004-07, Vol.25, p.S94-S94

2004

Volltextzugriff (PDF)

O4-04-07: Treatment of mild cognitive impairment with vitamin E and donepezil: Correlation between rates of change on MRI and cognitive/behavioral measures

Alzheimer's & dementia, 2006-07, Vol.2 (3), p.S84-S84

2006

Volltextzugriff (PDF)

P2-186: Treatment of mild cognitive impairment with vitamin E and donepezil: Correlations between serial MRI and conversion, genotype, and treatment status

Alzheimer's & dementia, 2006-07, Vol.2 (3), p.S289-S290

2006

Volltextzugriff (PDF)

IC-P-096: Treatment of mild cognitive impairment with vitamin E and donepezil: Correlations between serial MRI and conversion, genotype, and treatment status

Alzheimer's & dementia, 2006-07, Vol.2 (3), p.S691-S691

2006

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(37)

Sprache

Englisch
(37)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial

Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment

Impact of potential modifications to Alzheimer's disease clinical trials in response to disruption by COVID-19: a simulation study

Development of a novel cognitive composite outcome to assess therapeutic effects of exercise in the EXERT trial for adults with MCI: The ADAS‐Cog‐Exec

Incidence of new-onset seizures in mild to moderate Alzheimer disease

Depressed mood in informal caregivers of individuals with mild cognitive impairment

High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial

A Phase 2a proof‐of‐concept double‐blind, randomized, placebo‐controlled trial of nicotinamide in early Alzheimer’s disease

Spanish instrument protocol : New treatment efficacy instruments for spanish-speaking patients in Alzheimer disease clinical trials

Memantine and Acetylcholinesterase Inhibitor Use in Alzheimer's Disease Clinical Trials: Potential for Confounding by Indication

Topline Results of EXERT: Can Exercise Slow Cognitive Decline in MCI?

Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial

Birth outcomes in women who have taken leflunomide during pregnancy

Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia

Sample size requirements for training to a kappa agreement criterion on clinical dementia ratings

ADCS prevention instrument project: pharmacoeconomics : Assessing health-related resource use among healthy elderly

The multicenter AIDS cohort study : retention after 91/2 years

The Multicenter AIDS Cohort Study: retention after 9 1/2 years

Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials

S3-02-01: ADCS homocysteine trial

S3-02-01

P1-003 ADCS Prevention instrument project: assessment of activities of daily living (ADL)

O4-04-07: Treatment of mild cognitive impairment with vitamin E and donepezil: Correlation between rates of change on MRI and cognitive/behavioral measures

P2-186: Treatment of mild cognitive impairment with vitamin E and donepezil: Correlations between serial MRI and conversion, genotype, and treatment status

IC-P-096: Treatment of mild cognitive impairment with vitamin E and donepezil: Correlations between serial MRI and conversion, genotype, and treatment status

Suchergebnisse filtern